Accenture Equity Method Investments increased by 6.1% to $852.16M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 92.9%, from $441.72M to $852.16M. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows an upward trend with a 21.9% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $327.50M | $329.53M | $325.71M | $336.88M | $331.50M | $317.97M | $324.38M | $325.25M | $176.26M | $197.44M | $198.07M | $238.93M | $231.28M | $334.66M | $371.51M | $441.72M | $593.47M | $721.26M | $803.00M | $852.16M |
| QoQ Change | — | +0.6% | -1.2% | +3.4% | -1.6% | -4.1% | +2.0% | +0.3% | -45.8% | +12.0% | +0.3% | +20.6% | -3.2% | +44.7% | +11.0% | +18.9% | +34.4% | +21.5% | +11.3% | +6.1% |
| YoY Change | — | — | — | — | +1.2% | -3.5% | -0.4% | -3.5% | -46.8% | -37.9% | -38.9% | -26.5% | +31.2% | +69.5% | +87.6% | +84.9% | +156.6% | +115.5% | +116.1% | +92.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.